We performed a one-way ANOVA to analyze the subgroups of patients with CAA and showed rising CRP levels of clinical relevance with advanced clinical stages: phlegmonous (Md = 35.2, 11.9; 96.7), gangrenous (Md = 53.2; 15.9; 148.3), and perforated AA (Md = 108.4; 54.1; 179.2) and abscesses (Md = 101.8; 13.6; 192.9) (F = 30.19, p < 0.001; Figure 2a). This evidence concerns the gene CRP and abscess.